InTrack Investment Management Inc Invests $212,000 in Agilent Technologies, Inc. (NYSE:A)

InTrack Investment Management Inc purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, HoldingsChannel.com reports. The fund purchased 1,430 shares of the medical research company’s stock, valued at approximately $212,000.

Several other institutional investors have also recently made changes to their positions in A. Quantbot Technologies LP purchased a new position in Agilent Technologies in the first quarter valued at about $938,000. Cetera Investment Advisers grew its stake in Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after purchasing an additional 29,590 shares during the last quarter. iA Global Asset Management Inc. grew its stake in Agilent Technologies by 26.2% in the first quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock valued at $3,168,000 after purchasing an additional 4,523 shares during the last quarter. Bayesian Capital Management LP purchased a new position in Agilent Technologies in the first quarter valued at about $1,355,000. Finally, Nomura Holdings Inc. purchased a new position in Agilent Technologies in the fourth quarter valued at about $823,000.

Analyst Upgrades and Downgrades

Several research firms have issued reports on A. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI boosted their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. TD Cowen boosted their price target on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Bank of America boosted their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Citigroup boosted their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $143.64.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares in the company, valued at $3,650,640. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares in the company, valued at $3,650,640. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,953 shares of company stock valued at $2,013,630.

Agilent Technologies Trading Up 0.8 %

Shares of NYSE:A opened at $143.82 on Friday. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The company has a market capitalization of $41.32 billion, a PE ratio of 29.84, a PEG ratio of 6.96 and a beta of 1.05. The business has a 50 day moving average of $140.51 and a two-hundred day moving average of $138.94. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the company posted $1.43 earnings per share. Agilent Technologies’s revenue for the quarter was down 5.6% on a year-over-year basis. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s payout ratio is presently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.